I PEACE Logo (WIPO, 25.02.2020)
WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke I PEACE wurde als Wortmarke am 25.02.2020 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1539027 |
| Länder | 
|
| Basismarke |
Nr. 88596074,
28. August 2019
|
| Anmeldedatum | 25. Februar 2020 |
| Ablaufdatum | 25. Februar 2030 |
Markeninhaber
809 San Antonio Road, Suite #7
Palo Alto CA 94303
US
Palo Alto CA 94303
US
Markenvertreter
TMI Associates,
23rd Floor, Roppongi Hills Mori Tower,
JP
Waren und Dienstleistungen
10
Apparatus for the regeneration of stem cells for medical
purposes, namely, for gene editing, gene collection, and
gene production
11
Refrigerated medical container for storage, transportation
and cooling of medicines and pharmaceuticals, namely, frozen
storage containers for stem cells
36
Insurance services, namely, underwriting, issuance and
brokerage of stem cell insurance
40
Custom manufacture and non-custom manufacture of medical
devices to order and/or specification of others (terms too
vague in the opinion of the International Bureau – Rule 13
2)(b) of the regulations); custom manufacture and non-custom
manufacture of medical devices to order and/or specification
of others (terms too vague in the opinion of the
International Bureau – Rule 13(2)(b) of the regulations);
custom manufacture and non-custom manufacture of machinery
for generating stem cells to order and/or specification of
others (terms too vague in the opinion of the International
Bureau – Rule 13(2)(b) of the regulations); biomanufacturing
for others, namely, custom manufacturing and non-custom
manufacturing of clinical grade cells (terms too vague in
the opinion of the International Bureau – Rule 13(2)(b) of
the regulations); stem cell banking in the nature of stem
cell freezing services
42
Scientific and medical research in the field of stem cell,
gene research, and gene editing; blood analysis services;
medical and scientific research, namely, testing,
inspection, and research of stem cells; biological cloning
services, namely, organ reproduction services; biological
cloning services, namely, DNA, RNA and protein reproduction
services; testing, inspection, and research of cosmetics;
collection of biological materials, namely, stem cells for
scientific research purposes; medical and scientific
research services, namely, research in the field of stem
cells and gene diagnostics; DNA analysis services for
scientific research purposes; drug discovery services;
scientific research services, namely, research in the field
of regenerative medicine; stem cell and gene expression
analysis for scientific research purposes; stem cell and
epigenetic state analysis for scientific research purposes;
proteomic analysis for scientific research purposes
44
Stem cell and gene collection services for medical purposes
and research purposes; medical analysis services for
diagnostic and treatment purposes provided by medical
laboratories in the nature of stem cell and gene expression
analysis; medical analysis services for diagnostic and
treatment purposes provided by medical laboratories in the
nature of stem cell and epigenetic state analysis; medical
analysis services for diagnostic and treatment purposes
provided by medical laboratories in the nature of proteomic
analysis; healthcare; medical assistance; stem cell therapy
and stem cell production services for medical purposes and
research purposes (terms too vague in the opinion of the
International Bureau – Rule 13(2)(b) of the regulations);
cosmetic surgery services; stem cell therapy services,
namely, stem cell and gene transplantation services;
collection of biological materials, namely, stem cells for
medical treatment purposes; medical analysis services for
diagnostic and treatment purposes provided by medical
laboratories in the nature of stem cell and gene diagnostic
services; medical diagnostic and treatment services in the
field of regenerative medical services
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 22. Februar 2022 | 2022/8 Gaz | EM | Ablehnung |
| 19. Januar 2022 | 2022/3 Gaz | CN | Ablehnung |
| 13. Januar 2022 | 2022/3 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 10. Januar 2022 | 2022/8 Gaz | US | RAW: Partial Ceasing Effect |
| 13. August 2021 | 2021/37 Gaz | Korrektur | |
| 22. Juli 2021 | 2021/29 Gaz | JP | Ablehnung |
| 25. Februar 2020 | 2020/25 Gaz | US | Eintragung |
ID: 141539027